# Dermata Therapeutics, Inc.: Form 8-K, filed May 27, 2026

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: 8-K
- Filed: 2026-05-27
- Accepted by EDGAR: May 27, 2026, 16:57 ET
- Period: 2026-05-27
- Accession: 0001493152-26-025441
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226025441/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000149315226025441/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000149315226025441/form8-k.htm

Filed May 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-025441. Last ingested by Listed: Nov 2, 2026, 18:37 ET. No prices; not investment advice.